Exactech Director Albert H. Burstein sold 8,852 shares of the company's stock on Monday, Aug. 25, according to an InterCooler report.
The shares were sold at $23.72 average price, making the total transaction around $210,057. Mr. Burstein now directly owns 17,284 of the company's stock, valued at around $410,149. The day after the sale, Exactech shares traded down 0.80 percent during mid-day trading.
The company's stock opened at $23.57 on Aug. 27 with a market cap at $324.59 million. The company's 52-week low was $18.34 and high was $26.52. Recently, the company reported Jeffrey Pierson, MD, implanted its first Alteon Tapered Wedge Femoral Stem.
In the second quarter, the company reported $4.2 million in net income, which increased significantly over last year. Revenue was up 6 percent to $62.9 million. However, the company's spine and biologic revenue decreased 5 percent. Gross margins increased to 69.4.
Earlier in the summer, Executive Vice President sold more than 12,000 shares of the company, then sold another 16,000 shares a few weeks later.